ANDROSCIENCE CORPORATION

Basic Information

11175 FLINTKOTE AVE., SUITE F
SAN DIEGO, CA, 92121

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. A New Topical Antiandrogen Benefits Acne Treatment

    Amount: $801,607.00

    DESCRIPTION (provided by applicant): Acne is the second most expensive skin disease, resulting in $2.23 billion in medical spending annually. Although the overall health is not impaired, acne can prod ...

    SBIR Phase II 2006 Department of Health and Human Services
  2. A New Topical Antiandrogen Benefits Acne Treatment

    Amount: $100,001.00

    DESCRIPTION (provided by applicant): Acne is the most common skin disorder encountered by physicians. It affects 80% of all persons between the ages of 11 and 30 years. Although the overall health ...

    SBIR Phase I 2004 Department of Health and Human Services
  3. CELL-BASED HIGH THROUGHPUT SCREENING FOR ANTI-ANDROGENS

    Amount: $100,000.00

    DESCRIPTION (provided by the applicant): Prostate cancer is the most frequently diagnosed cancer in American men and the second leading cause of male cancer death. Antiandrogens have been ...

    SBIR Phase I 2002 Department of Health and Human Services
  4. ANTI-ANDROGENIC MECHANISM OF A NEW COMPOUND

    Amount: $99,750.00

    DESCRIPTION (provided by applicant): Androgen blockage therapy may relieve the symptom of an advanced, localized prostate tumor; however, once the tumor evolves into a hormone-refractory stage, there ...

    STTR Phase I 2002 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government